AIMIRA Innovation Technology is a pioneering AI-based medical technology startup founded in 2021. Their slogan "Pioneering AI-driven advancements in diagnosis, aesthetic plastic surgery, and anti-aging medicine" reflects their focus. Having secured a CNY100.00M Seed Round investment on 05 September 2023, they have garnered support from notable investors including Boyuan Capital, 深圳市创东方投资有限公司, 金鼎资本, and Fosun Health Capital. AIMIRA's innovative approach to AI-driven solutions in the medical field positions them as a promising venture with potential for significant impact in the industry. With a strong focus on diagnosis, aesthetic plastic surgery, and anti-aging medicine, AIMIRA is well-positioned to capitalize on the growing demand for advanced medical technologies driven by AI.
No recent news or press coverage available for AIMIRA Innovation Technology.